Cargando…
Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans
AIMS: A study of 222 candidate genes in type 2 diabetes reported association of variants in RAPGEF1, ENPP1, TP53, NRF1, SLC2A2, SLC2A4 and FOXC2 with type 2 diabetes in 4,805 Finnish individuals. We aimed to replicate these associations in a Danish case-control study and to substantiate any replicat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024396/ https://www.ncbi.nlm.nih.gov/pubmed/21283750 http://dx.doi.org/10.1371/journal.pone.0015813 |
_version_ | 1782196781191266304 |
---|---|
author | Burgdorf, Kristoffer Sølvsten Grarup, Niels Justesen, Johanne Marie Harder, Marie Neergaard Witte, Daniel Rinse Jørgensen, Torben Sandbæk, Annelli Lauritzen, Torsten Madsbad, Sten Hansen, Torben Pedersen, Oluf |
author_facet | Burgdorf, Kristoffer Sølvsten Grarup, Niels Justesen, Johanne Marie Harder, Marie Neergaard Witte, Daniel Rinse Jørgensen, Torben Sandbæk, Annelli Lauritzen, Torsten Madsbad, Sten Hansen, Torben Pedersen, Oluf |
author_sort | Burgdorf, Kristoffer Sølvsten |
collection | PubMed |
description | AIMS: A study of 222 candidate genes in type 2 diabetes reported association of variants in RAPGEF1, ENPP1, TP53, NRF1, SLC2A2, SLC2A4 and FOXC2 with type 2 diabetes in 4,805 Finnish individuals. We aimed to replicate these associations in a Danish case-control study and to substantiate any replicated associations in meta-analyses. Furthermore, we evaluated the impact on diabetes-related intermediate traits in a population-based sample of middle-aged Danes. METHODS: We genotyped nine lead variants in the seven genes in 4,973 glucose-tolerant and 3,612 type 2 diabetes Danish individuals. In meta-analyses we combined case-control data from the DIAGRAM+ Consortium (n = 47,117) and the present genotyping results. The quantitative trait studies involved 5,882 treatment-naive individuals from the Danish Inter99 study. RESULTS: None of the nine investigated variants were significantly associated with type 2 diabetes in the Danish samples. However, for all nine variants the estimate of increase in type 2 diabetes risk was observed for the same allele as previously reported. In a meta-analysis of published and online data including 55,521 Europeans the G-allele of rs1042522 in TP53 showed significant association with type 2 diabetes (OR = 1.06 95% CI 1.02–1.11, p = 0.0032). No substantial associations with diabetes-related intermediary phenotypes were found. CONCLUSION: The G-allele of TP53 rs1042522 is associated with an increased prevalence of type 2 diabetes in a combined analysis of 55,521 Europeans. |
format | Text |
id | pubmed-3024396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30243962011-01-31 Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans Burgdorf, Kristoffer Sølvsten Grarup, Niels Justesen, Johanne Marie Harder, Marie Neergaard Witte, Daniel Rinse Jørgensen, Torben Sandbæk, Annelli Lauritzen, Torsten Madsbad, Sten Hansen, Torben Pedersen, Oluf PLoS One Research Article AIMS: A study of 222 candidate genes in type 2 diabetes reported association of variants in RAPGEF1, ENPP1, TP53, NRF1, SLC2A2, SLC2A4 and FOXC2 with type 2 diabetes in 4,805 Finnish individuals. We aimed to replicate these associations in a Danish case-control study and to substantiate any replicated associations in meta-analyses. Furthermore, we evaluated the impact on diabetes-related intermediate traits in a population-based sample of middle-aged Danes. METHODS: We genotyped nine lead variants in the seven genes in 4,973 glucose-tolerant and 3,612 type 2 diabetes Danish individuals. In meta-analyses we combined case-control data from the DIAGRAM+ Consortium (n = 47,117) and the present genotyping results. The quantitative trait studies involved 5,882 treatment-naive individuals from the Danish Inter99 study. RESULTS: None of the nine investigated variants were significantly associated with type 2 diabetes in the Danish samples. However, for all nine variants the estimate of increase in type 2 diabetes risk was observed for the same allele as previously reported. In a meta-analysis of published and online data including 55,521 Europeans the G-allele of rs1042522 in TP53 showed significant association with type 2 diabetes (OR = 1.06 95% CI 1.02–1.11, p = 0.0032). No substantial associations with diabetes-related intermediary phenotypes were found. CONCLUSION: The G-allele of TP53 rs1042522 is associated with an increased prevalence of type 2 diabetes in a combined analysis of 55,521 Europeans. Public Library of Science 2011-01-20 /pmc/articles/PMC3024396/ /pubmed/21283750 http://dx.doi.org/10.1371/journal.pone.0015813 Text en Burgdorf et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Burgdorf, Kristoffer Sølvsten Grarup, Niels Justesen, Johanne Marie Harder, Marie Neergaard Witte, Daniel Rinse Jørgensen, Torben Sandbæk, Annelli Lauritzen, Torsten Madsbad, Sten Hansen, Torben Pedersen, Oluf Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans |
title | Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans |
title_full | Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans |
title_fullStr | Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans |
title_full_unstemmed | Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans |
title_short | Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans |
title_sort | studies of the association of arg72pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 europeans |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024396/ https://www.ncbi.nlm.nih.gov/pubmed/21283750 http://dx.doi.org/10.1371/journal.pone.0015813 |
work_keys_str_mv | AT burgdorfkristoffersølvsten studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT grarupniels studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT justesenjohannemarie studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT hardermarieneergaard studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT wittedanielrinse studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT jørgensentorben studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT sandbækannelli studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT lauritzentorsten studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT madsbadsten studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT hansentorben studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans AT pedersenoluf studiesoftheassociationofarg72prooftumorsuppressorproteinp53withtype2diabetesinacombinedanalysisof55521europeans |